Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Molecular Cancer Therapeutics|May 7, 2020
FGFR Inhibition Enhances Sensitivity to Radiation in Non-Small Cell Lung CancerGopika SenthilKumar, Michael M Fisher, Justin H Skiba, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 21, 2017
The significance of Trk receptors in pancreatic cancerMatthew D Johnson, Brandon Stone, Bryan J Thibodeau, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2020
Fibroblast Growth Factor Receptors as Targets for Radiosensitization in Head and Neck Squamous Cell CarcinomasMichael M Fisher, Gopika SenthilKumar, Rong Hu, et al.
Molecular Cancer Therapeutics|August 20, 2021
ATR Inhibitor M6620 (VX-970) Enhances the Effect of Radiation in Non-Small Cell Lung Cancer Brain Metastasis Patient-Derived XenograftsAndrew M Baschnagel, Jacob H Elnaggar, Haley J VanBeek, et al.
Clinical Lung Cancer|September 6, 2024
DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung CancerChristine M Bestvina, Jared H L Hara, Theodore Karrison, et al.
Advances in Radiation Oncology|May 7, 2025
National Institutes of Health Funding to Support Radiation Oncology Research: A Comparative Trend Analysis Over a Decade, 2011-2021Amir Razavi, Michael K Rooney, Clifton D Fuller, et al.
Cureus|June 7, 2018
A New Era of Image Guidance with Magnetic Resonance-guided Radiation Therapy for Abdominal and Thoracic MalignanciesKathryn Mittauer, Bhudatt Paliwal, Patrick Hill, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2023
Toxicity and Patient-Reported Quality-of-Life Outcomes After Prostate Stereotactic Body Radiation Therapy With Focal Boost to Magnetic Resonance Imaging-Identified Prostate Cancer Lesions: Results of a Phase 2 TrialBrett A Morris, Emma E Holmes, Nicholas J Anger, et al.
International Journal of Radiation Oncology, Biology, Physics|December 10, 2023
Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase 1b TrialMichael F Bassetti, Brett A Morris, Nan Sethakorn, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2017
Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine ConferenceWilliam A Hall, Carmen Bergom, Reid F Thompson, et al.
Pageof 7